Division of Transplant Surgery and Transplant Surgery Research Laboratory, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts 02115, USA.
Curr Opin Organ Transplant. 2011 Apr;16(2):162-8. doi: 10.1097/MOT.0b013e3283446b07.
Hypothermic static organ preservation remains the Standard of Care in renal transplantation. At the same time, novel perfusion and preservation concepts are under current investigation and have shown promising results.We summarize the current knowledge and controversies in hypothermic kidney preservation.
The ideal organ perfusate remains a matter of ongoing debate and prospective randomized clinical trials supporting the superiority of one organ preservation solution remain limited. Ideally, a concept of one preservation solution serving the needs of all organs may best serve practicality and cost-effectiveness. At the same time, organ-specific aspects and the role of organ quality linking perfusion and preservation continue to be discussed controversially.Hypothermic pulsatile perfusion has gained increasing attention with some of the recent clinical trials demonstrating improved transplant survival. However, not all recent clinical studies have been in support of machine perfusion and preservation. Composition of the perfusate, potential benefits of oxygenation, length of preservation, and dissecting a potential advantage of pulsatile over continuous flow patterns will be additional critical steps in working towards an optimized organ preservation. At the same time, studies into mechanisms and indications for pulsatile perfusion will need more attention.
Organ preservation is a critical aspect for the overall success in organ transplantation. The current increased utilization of reduced quality kidneys will require us to further improve our practice and knowledge into optimized organ preservation concepts and their impact on transplant outcome and immune responsiveness.
低温静态器官保存仍然是肾移植的标准治疗方法。与此同时,新的灌注和保存概念正在研究中,并取得了有希望的结果。我们总结了低温肾保存的当前知识和争议。
理想的器官灌注液仍然是一个持续争论的问题,支持一种器官保存溶液优越性的前瞻性随机临床试验仍然有限。理想情况下,一种能够满足所有器官需求的保存溶液概念可能最能兼顾实用性和成本效益。同时,器官特异性方面和灌注与保存之间的器官质量联系的作用仍在争议中。低温搏动性灌注越来越受到关注,一些最近的临床试验表明移植存活率有所提高。然而,并非所有最近的临床研究都支持机器灌注和保存。灌流液的组成、氧合的潜在益处、保存时间以及搏动流与持续流模式的潜在优势的区分,将是朝着优化器官保存方向发展的关键步骤。同时,需要更多关注关于搏动性灌注的机制和适应证的研究。
器官保存是器官移植整体成功的关键方面。目前,低质量肾脏的利用率增加,这将要求我们进一步改进我们的实践和知识,以优化器官保存概念及其对移植结果和免疫反应性的影响。